Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Barohn

Showing results (111-120 of 179) with videos related to

Pageof 18
Sort By:
Journal of Clinical Neuromuscular Disease|December 17, 2008
Primary lateral sclerosis: clinical and laboratory features in 25 patientsMike A Singer, Suleiman Kojan, Richard J Barohn, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 18, 2015
Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALSRobert G Miller, Gilbert Block, Jonathan S Katz, et al.
Neurology|September 1, 2017
High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2James E Hilbert, Richard J Barohn, Paula R Clemens, et al.
Annals of Neurology|April 27, 2005
Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositisSteven A Greenberg, Jack L Pinkus, Geraldine S Pinkus, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 3, 2024
Measurement properties of the Inclusion Body Myositis Functional Rating ScaleSharfaraz Salam, Tara Symonds, Helen Doll, et al.
Neuromuscular Disorders : NMD|May 30, 2015
Disease course and therapeutic approach in dermatomyositis: A four-center retrospective study of 100 patientsNicholas E Johnson, W David Arnold, Donald Hebert, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 8, 2020
Primary lateral sclerosis: consensus diagnostic criteriaMartin R Turner, Richard J Barohn, Philippe Corcia, et al.
Neurology. Genetics|April 12, 2016
Phenotypic and molecular analyses of primary lateral sclerosisHiroshi Mitsumoto, Peter L Nagy, Chris Gennings, et al.
Trials|September 1, 2016
A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomizationAlexandra R Brown, Byron J Gajewski, Lauren S Aaronson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2014
Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositisRohit Aggarwal, Andriy Bandos, Ann M Reed, et al.
Pageof 18

Showing results (111-120 of 179) with videos related to

Sort By:
Pageof 18
Journal of Clinical Neuromuscular Disease|December 17, 2008
Primary lateral sclerosis: clinical and laboratory features in 25 patientsMike A Singer, Suleiman Kojan, Richard J Barohn, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 18, 2015
Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALSRobert G Miller, Gilbert Block, Jonathan S Katz, et al.
Neurology|September 1, 2017
High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2James E Hilbert, Richard J Barohn, Paula R Clemens, et al.
Annals of Neurology|April 27, 2005
Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositisSteven A Greenberg, Jack L Pinkus, Geraldine S Pinkus, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 3, 2024
Measurement properties of the Inclusion Body Myositis Functional Rating ScaleSharfaraz Salam, Tara Symonds, Helen Doll, et al.
Neuromuscular Disorders : NMD|May 30, 2015
Disease course and therapeutic approach in dermatomyositis: A four-center retrospective study of 100 patientsNicholas E Johnson, W David Arnold, Donald Hebert, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 8, 2020
Primary lateral sclerosis: consensus diagnostic criteriaMartin R Turner, Richard J Barohn, Philippe Corcia, et al.
Neurology. Genetics|April 12, 2016
Phenotypic and molecular analyses of primary lateral sclerosisHiroshi Mitsumoto, Peter L Nagy, Chris Gennings, et al.
Trials|September 1, 2016
A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomizationAlexandra R Brown, Byron J Gajewski, Lauren S Aaronson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2014
Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositisRohit Aggarwal, Andriy Bandos, Ann M Reed, et al.
Pageof 18